Spontaneous and treatment-induced cancer rejection in humans

Ena Wang, Silvia Selleri, Marianna Sabatino, Alessandro Monaco, Zoltan Pos, Andrea Worschech, David F. Stroncek, Francesco M. Marincola

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Background: Experimental observations suggest that human cancer cells actively interact with normal host cells and this cross-talk results, in most instances, in an increased potential of cancer cells to survive. On the other hand, it is also well documented that on rare occasions tumors can be dramatically destroyed by the host's immune response. Objective: In this review, we argue that understanding the mechanisms that bring about the immune response and lead to cancer destruction is of paramount importance for the design of future rational therapies. Methods: Here we summarize the present understanding of the phenomenology leading to cancer regression in humans and propose novel strategies for a more efficient study of human cancer under natural conditions and during therapy. Conclusion: The understanding of tumor/host interactions within the tumor microenvironment is a key component of the study of tumor immunology in humans, much can be learned by a dynamic study of such interactions at time points related to the natural history of the disease or its response to therapy. Such understanding will eventually lead to novel and more effective therapies.

Original languageEnglish
Pages (from-to)337-349
Number of pages13
JournalExpert Opinion on Biological Therapy
Volume8
Issue number3
DOIs
Publication statusPublished - Mar 2008
Externally publishedYes

Fingerprint

Tumors
Neoplasms
Cells
Immunology
Tumor Microenvironment
Therapeutics
Allergy and Immunology

Keywords

  • Functional genomics
  • Immunotherapy
  • Melanoma
  • Microarrays
  • Renal cell cancer
  • Tumor immunology

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology

Cite this

Wang, E., Selleri, S., Sabatino, M., Monaco, A., Pos, Z., Worschech, A., ... Marincola, F. M. (2008). Spontaneous and treatment-induced cancer rejection in humans. Expert Opinion on Biological Therapy, 8(3), 337-349. https://doi.org/10.1517/14712598.8.3.337

Spontaneous and treatment-induced cancer rejection in humans. / Wang, Ena; Selleri, Silvia; Sabatino, Marianna; Monaco, Alessandro; Pos, Zoltan; Worschech, Andrea; Stroncek, David F.; Marincola, Francesco M.

In: Expert Opinion on Biological Therapy, Vol. 8, No. 3, 03.2008, p. 337-349.

Research output: Contribution to journalReview article

Wang, E, Selleri, S, Sabatino, M, Monaco, A, Pos, Z, Worschech, A, Stroncek, DF & Marincola, FM 2008, 'Spontaneous and treatment-induced cancer rejection in humans', Expert Opinion on Biological Therapy, vol. 8, no. 3, pp. 337-349. https://doi.org/10.1517/14712598.8.3.337
Wang, Ena ; Selleri, Silvia ; Sabatino, Marianna ; Monaco, Alessandro ; Pos, Zoltan ; Worschech, Andrea ; Stroncek, David F. ; Marincola, Francesco M. / Spontaneous and treatment-induced cancer rejection in humans. In: Expert Opinion on Biological Therapy. 2008 ; Vol. 8, No. 3. pp. 337-349.
@article{28ad0ce4036941fb9200440f5fcd14ec,
title = "Spontaneous and treatment-induced cancer rejection in humans",
abstract = "Background: Experimental observations suggest that human cancer cells actively interact with normal host cells and this cross-talk results, in most instances, in an increased potential of cancer cells to survive. On the other hand, it is also well documented that on rare occasions tumors can be dramatically destroyed by the host's immune response. Objective: In this review, we argue that understanding the mechanisms that bring about the immune response and lead to cancer destruction is of paramount importance for the design of future rational therapies. Methods: Here we summarize the present understanding of the phenomenology leading to cancer regression in humans and propose novel strategies for a more efficient study of human cancer under natural conditions and during therapy. Conclusion: The understanding of tumor/host interactions within the tumor microenvironment is a key component of the study of tumor immunology in humans, much can be learned by a dynamic study of such interactions at time points related to the natural history of the disease or its response to therapy. Such understanding will eventually lead to novel and more effective therapies.",
keywords = "Functional genomics, Immunotherapy, Melanoma, Microarrays, Renal cell cancer, Tumor immunology",
author = "Ena Wang and Silvia Selleri and Marianna Sabatino and Alessandro Monaco and Zoltan Pos and Andrea Worschech and Stroncek, {David F.} and Marincola, {Francesco M.}",
year = "2008",
month = "3",
doi = "10.1517/14712598.8.3.337",
language = "English",
volume = "8",
pages = "337--349",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Spontaneous and treatment-induced cancer rejection in humans

AU - Wang, Ena

AU - Selleri, Silvia

AU - Sabatino, Marianna

AU - Monaco, Alessandro

AU - Pos, Zoltan

AU - Worschech, Andrea

AU - Stroncek, David F.

AU - Marincola, Francesco M.

PY - 2008/3

Y1 - 2008/3

N2 - Background: Experimental observations suggest that human cancer cells actively interact with normal host cells and this cross-talk results, in most instances, in an increased potential of cancer cells to survive. On the other hand, it is also well documented that on rare occasions tumors can be dramatically destroyed by the host's immune response. Objective: In this review, we argue that understanding the mechanisms that bring about the immune response and lead to cancer destruction is of paramount importance for the design of future rational therapies. Methods: Here we summarize the present understanding of the phenomenology leading to cancer regression in humans and propose novel strategies for a more efficient study of human cancer under natural conditions and during therapy. Conclusion: The understanding of tumor/host interactions within the tumor microenvironment is a key component of the study of tumor immunology in humans, much can be learned by a dynamic study of such interactions at time points related to the natural history of the disease or its response to therapy. Such understanding will eventually lead to novel and more effective therapies.

AB - Background: Experimental observations suggest that human cancer cells actively interact with normal host cells and this cross-talk results, in most instances, in an increased potential of cancer cells to survive. On the other hand, it is also well documented that on rare occasions tumors can be dramatically destroyed by the host's immune response. Objective: In this review, we argue that understanding the mechanisms that bring about the immune response and lead to cancer destruction is of paramount importance for the design of future rational therapies. Methods: Here we summarize the present understanding of the phenomenology leading to cancer regression in humans and propose novel strategies for a more efficient study of human cancer under natural conditions and during therapy. Conclusion: The understanding of tumor/host interactions within the tumor microenvironment is a key component of the study of tumor immunology in humans, much can be learned by a dynamic study of such interactions at time points related to the natural history of the disease or its response to therapy. Such understanding will eventually lead to novel and more effective therapies.

KW - Functional genomics

KW - Immunotherapy

KW - Melanoma

KW - Microarrays

KW - Renal cell cancer

KW - Tumor immunology

UR - http://www.scopus.com/inward/record.url?scp=41149088426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149088426&partnerID=8YFLogxK

U2 - 10.1517/14712598.8.3.337

DO - 10.1517/14712598.8.3.337

M3 - Review article

C2 - 18294104

AN - SCOPUS:41149088426

VL - 8

SP - 337

EP - 349

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 3

ER -